Korro Bio (KRRO) Debt to Equity (2019 - 2023)
Korro Bio (KRRO) has disclosed Debt to Equity for 4 consecutive years, with -$0.1 as the latest value for Q1 2023.
- For the quarter ending Q1 2023, Debt to Equity fell 174.12% year-over-year to -$0.1, compared with a TTM value of -$0.1 through Mar 2023, down 174.12%, and an annual FY2022 reading of -$0.14, up 59.75% over the prior year.
- Debt to Equity was -$0.1 for Q1 2023 at Korro Bio, up from -$0.14 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.18 in Q3 2022 and bottomed at -$0.36 in Q4 2021.
- Average Debt to Equity over 4 years is $0.02, with a median of $0.09 recorded in 2021.
- The sharpest move saw Debt to Equity tumbled 556.05% in 2021, then skyrocketed 79.47% in 2022.
- Year by year, Debt to Equity stood at $0.08 in 2020, then crashed by 556.05% to -$0.36 in 2021, then soared by 59.75% to -$0.14 in 2022, then soared by 31.02% to -$0.1 in 2023.
- Business Quant data shows Debt to Equity for KRRO at -$0.1 in Q1 2023, -$0.14 in Q4 2022, and $0.18 in Q3 2022.